Active	Status	Sponsor type	Region	Phase	Filter
6 Active 1 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vranckx, Pascal
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation	Recruiting	4	3010	Europe	P2Y12 inhibitor, Aspirin, DOAC	Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited	Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor	09/26	12/26
REVERSE-IT, NCT04286438 / 2019-004457-92: Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure	Completed	3	226	Europe, Canada, US, RoW	Bentracimab (PB2452) Infusion	SFJ Pharmaceuticals, Inc.	Hemorrhage, Urgent Surgery, Invasive Procedure	09/24	09/24
COL BE PCI, NCT06095765: Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention	Recruiting	3	2770	Europe	Colchicine 0.5 MG Oral Tablet, Placebo	AZ Sint-Jan AV, University Hospital, Ghent, Belgium Health Care Knowledge Centre	Coronary Artery Disease	11/27	03/28
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Active, not recruiting	N/A	418	Europe, Canada, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation	Coronary Restenosis	07/25	08/29
AI-ECG TIMI, NCT06528821: AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS	Recruiting	N/A	800	Europe		Powerful Medical	Acute Coronary Syndrome, STEMI, Coronary Occlusion, Coronary Syndrome, NSTEMI, NSTEMI - Non-ST Segment Elevation MI	10/25	10/25
Jansen, Arne
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Active, not recruiting	N/A	418	Europe, Canada, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation	Coronary Restenosis	07/25	08/29

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vranckx, Pascal
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation	Recruiting	4	3010	Europe	P2Y12 inhibitor, Aspirin, DOAC	Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited	Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor	09/26	12/26
REVERSE-IT, NCT04286438 / 2019-004457-92: Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure	Completed	3	226	Europe, Canada, US, RoW	Bentracimab (PB2452) Infusion	SFJ Pharmaceuticals, Inc.	Hemorrhage, Urgent Surgery, Invasive Procedure	09/24	09/24
COL BE PCI, NCT06095765: Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention	Recruiting	3	2770	Europe	Colchicine 0.5 MG Oral Tablet, Placebo	AZ Sint-Jan AV, University Hospital, Ghent, Belgium Health Care Knowledge Centre	Coronary Artery Disease	11/27	03/28
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Active, not recruiting	N/A	418	Europe, Canada, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation	Coronary Restenosis	07/25	08/29
AI-ECG TIMI, NCT06528821: AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS	Recruiting	N/A	800	Europe		Powerful Medical	Acute Coronary Syndrome, STEMI, Coronary Occlusion, Coronary Syndrome, NSTEMI, NSTEMI - Non-ST Segment Elevation MI	10/25	10/25
Jansen, Arne
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Active, not recruiting	N/A	418	Europe, Canada, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation	Coronary Restenosis	07/25	08/29